ONDCP Seal



News Home

Press Releases

Speeches

Testimony
   2008
   2007
   2006
   2005
   2004
   2003
   2002
   2001


Op-Ed

Conference Calendar

Fentanyl-Laced Heroin Forum

Skip NavigationNews and Public AffairsONDCP Mast
Search Contact Podcast Mobile Web Blog ONDCP Mast
ONDCP Web Site About ONDCP News and Public Affairs Policy Drug Facts Publications Related Links
Prevention Treatment Science and Technology Enforcement State and Local International Funding
Start of Main Content

"The Office of National Drug Control Policy's FY 2004
Budget Request"

April 9, 2003

  1. Other Federal Drug Control Programs: $250 million.

ONDCP's FY 2004 budget requests $250 million for the Other Federal Drug Control Programs. ONDCP requested $251.300 million in FY 2003. The FY 2003 enacted level is $221.749 million. Since FY 1998, the Special Forfeiture Fund (SFF) funding has been solely based on appropriations from Congress. Therefore, in FY 2004 we are requesting to change the name of the Special Forfeiture Fund to Other Federal Drug Control Programs. This account provides funds to a diverse group of ongoing programs: the National Youth Anti-Drug Media Campaign, the Drug-Free Communities Program, the U.S. Olympic Anti-Doping Agency, the Counterdrug Intelligence Executive Secretariat, the National Drug Court Institute, Performance Measures Development and World Anti-Doping Agency (WADA) Membership Dues.

The National Youth Anti-Drug Media Campaign: $170 million.

In FY 2004, ONDCP is requesting $170 million for the National Youth Anti-Drug Media Campaign. ONDCP requested $180 million in FY 2003. The FY 2003 enacted level is $149.025 million. The Media Campaign uses multi-media advertising and public communications strategies aimed at youth and parents to promote anti-drug attitudes and behavior. The Campaign is a comprehensive national effort that integrates paid advertising at national and local levels with public information and entertainment industry outreach through a network of public and private partnerships. The Campaign is covered in detail under my written statement for the Subcommittee.

The Drug-Free Communities Support Program: $70 million.

In FY 2004, ONDCP is requesting $70 million for the Drug-Free Communities Support Program (DFCSP). ONDCP requested $60 million in FY 2003. The FY 2003 enacted level is $59.610 million. The DFCSP provides a competitive process to award matching federal grants of up to $100,000 per year directly to local community anti-drug coalitions for the purpose of supporting local efforts to prevent or reduce drug use among youth. After five years of operation (FY 1998 - FY 2002), the program currently supports community coalitions in 530 communities in all 50 states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands. Together, these community anti-drug coalitions serve a national network of local citizens, community leaders, and key professionals working daily to help keep young people free of the well-known dangers of drug use, including the underage use of alcohol and tobacco. Approximately 30 of the DFCSP grants have been awarded to communities where American Indian or Alaskan Native youth are the majority of young people served. Approximately 40% of DFCSP grants go to communities in small towns and rural areas.

In the fourth quarter of FY 2003, the program anticipates awarding approximately 440 continuation grants to existing grantees and approximately 160 new competitive grants. This will bring the total number of supported communities to approximately 600 by October 1, 2003. In addition, the DFCSP will award up to 25 supplemental grants to some of the most successful current grantees for the purpose of providing mentoring to other coalitions that may need such specialized assistance. This new activity is being supported for the first time in FY 2003 and is based on the common-sense idea that successful, experienced coalitions can provide valuable help to fledgling coalitions in other communities. Supplemental grants in amounts up to $75,000 will be awarded on a competitive basis and must be matched by other contributions or in-kind support.

Of the total amount of $70 million that ONDCP is requesting for this program in FY 2004, $64.8 million will be awarded in grants to as many as 700 community coalitions. An additional $1 million is planned to continue support for the National Community Coalition Institute which operates from a base at the Community Anti-Drug Coalitions of America (CADCA). The Coalition Institute exists to provide much-needed training and technical assistance to the growing number of coalitions around the country. A special emphasis of the Coalition Institute is to support individuals and groups in starting or improving coalitions in economically disadvantaged communities.

To operate the DFCSP, ONDCP works in partnership with the Deptartment of Justice's Office of Juvenile Justice and Delinquency Prevention (OJJDP) and the Department of Health and Human Service's Center for Substance Abuse Prevention (DHHS/SAMHSA/CSAP). OJJDP operates the day-to-day grants management function of the Drug-Free Communities Program and CSAP manages the grant supporting the Coalition Institute. In addition, ONDCP brings together multiple other resources from the federal and state governments as well as key private sector organizations to better assist America's communities. The communities themselves provide ONDCP with valuable, community-level, views of the current drug risks that imperil America's young people.

Of the total of $70 million, $4.2 million (6%) is requested for all administrative support for the Drug-Free Communities Program. ONDCP plans to allocate $250,000 for costs associated with the position of program administrator and the eleven member Advisory Commission on Drug-Free Communities; $3,890,000 to OJJDP for grants management, program monitoring and evaluation; and $60,000 to CSAP for grants management costs associated with the National Anti-Drug Coalition Institute. To avoid duplication of efforts and to ensure greater collaboration at the national level, the Coalition Institute is expected to work in close cooperation with CSAP's five regional Centers for the Application of Prevention Technology.

In summary, the Drug-Free Communities Program has grown into a key component of our nation's drug prevention infrastructure and constitutes a valuable part of our National Drug Control Strategy.

World Anti-Doping Agency Membership Dues: $1 million

In FY 2004, ONDCP is requesting $1 million for World Anti-Doping Agency (WADA) Membership Dues. ONDCP requested $0.800 million in FY 2003. The FY 2003 enacted level is $0.795 million. The dues assessment is formula driven and accounts for the increase from FY 2003.

WADA receives its funding in equal amounts from the International Olympic Committee and world governments. Governments are divided into six geographic regions. The U.S., along with Canada, Central America, the Caribbean, and South America, are part of the Americas region. The Americas region is required to contribute 28% of the governments funding. The U.S. contributes approximately 40% of the Americas' amount. As of FY 2004, the U.S. dues assessment is based upon our Olympic participation and contribution levels to the Organization of American States (OAS). The $1 million contribution is in line with contributions received by WADA from other countries with large Olympic participation. For example, Japan annually contributes $1.5 million and several European nations (including Italy, Russia, the United Kingdom, Germany, and France) contribute more than $500,000 despite smaller participation levels. In total, approximately fifty world governments contribute to WADA.

WADA was created in November 2001 to promote and coordinate the fight against the growing problem of doping and drug use in international sports. WADA is a partnership between world governments, intergovernmental organizations, the Olympic movement, athletes, and other entities concerned about the consequences of doping in sport. WADA's mission is to promote healthy, doping free sport at the international level. In addition to drug testing, WADA's budget funds education and prevention programs for athletes at all age and levels (with a particular emphasis on youth) and research related to drug use in sport.

A major accomplishment of WADA in FY 2003 was the creation and adoption of the World Anti-Doping Code. The Code creates harmonized international rules across sports that will govern the use of drugs and doping in sports. These new regulations will bring a degree of uniformity to the previously disjointed and inconsistent worldwide fight against drug use in sports. More than 70 nations and every Olympic sport federation has agreed to implement the contents of the Code. Particular care has been retained to ensure that implementation will be accomplished in a manner that recognizes the unique nature of sport regulation in the legal systems of the world, including the U.S. ONDCP was particularly pleased that the Code addresses not only drugs and substances that enhance athletic performance, but also drugs that endanger the health and safety of athletes and violate the spirit of sport, such as marijuana.

On August 9, 2000, Executive Order 13165 was signed, formalizing the role of ONDCP in addressing the use of drugs in sports and representing the U.S. Government in WADA activities. Since that date, ONDCP has played a major role in the governance and accomplishments of WADA. The Director of ONDCP serves on the organization's Governing Foundation Board. In addition, ONDCP's Deputy Director for Demand Reduction chairs the prestigious and influential Ethics and Education Committee. This WADA committee is entrusted with developing educational initiatives for athletes about the dangers and consequences of drug use in sports. Programs under the committee's jurisdiction include a youth awareness outreach initiative and an athlete's passport program that assists testing agencies locate athletes for out-of-competition drug testing.

United States Anti-Doping Agency: $1.5 million.

In FY 2004, ONDCP is requesting $1.5 million to support the United States Anti-Doping Agency (USADA). ONDCP requested $1 million in FY 2003. The FY 2003 enacted level is $6.358 million. Since FY 2002, funding to support USADA has been passed directly from ONDCP to USADA. USADA is a non-profit entity under the leadership of an independent Board of Directors.

Drug use and doping in sports is a growing problem in the U.S. Far too many American athletes, at all competition levels, are using steroids and other performance enhancing drugs in an attempt to improve their athletic prowess and/or their physical appearance. In the process, they are jeopardizing their health and undermining the core values of sport. As a result, USADA was established to lead a comprehensive anti-doping program in the U.S. USADA began operations October 1, 2000 with full authority for drug testing, education, research and adjudication for U.S. Olympic, Pan Am Games, and Paralympic athletes. Congress and the President have subsequently recognized USADA as the official anti-doping agency for the above-state purposes. (Public Law 107-67) Since its inception, USADA has received worldwide acclaim for its effective and innovative testing and education initiatives.

The $1.5 million request would support USADA's ongoing drug testing regime that includes management, sample collection and testing procedures. The FY 2004 request considers the increased adjudication costs as the result of increased testing and the implementation of blood testing, which is more costly (and accurate) than urine drug testing. The request would also fund drug-related research, educational programs aimed at school-aged athletes and coaches, efforts to inform athletes of the rules governing the use of performance enhancing substances, and the ethics of doping and its harmful health effects. The public awareness efforts will be particularly important since the World Anti-Doping Agency passed a new universal Code in March 2003 that will govern U.S. amateur athletes.

Counterdrug Intelligence Executive Secretariat: $4.5 million.

In FY 2004, ONDCP is requesting $4.5 million for the administration and operations of the Counter-drug Intelligence Executive Secretariat (CDX). ONDCP requested $6 million in FY 2003. The FY 2003 enacted level is $2.981 million. With this funding request, the CDX staff should complete implementation of the remaining action items in the General Counter-drug Intelligence Plan and in April 2004 will consider reducing the scope of their operations by the end of the Fiscal Year.

National Drug Court Institute: $1 million.

In FY 2004, ONDCP is requesting $1 million for the National Drug Court Institute (NDCI). ONDCP requested $1 million in FY 2003. The FY 2003 enacted level is $0.994 million. The Institute's education, research and scholarship programs require these funds: to continue the expansion of its discipline-specific and topic-specific drug court training programs for practitioners; to convene regional evaluation trainings in order to provide a forum for practitioners and researchers to enhance drug court evaluation techniques; to continue to publish and disseminate monographs on important and timely drug court issues; to continue to publish and disseminate the National Drug Court Institute Review; and to continue to publish and disseminate best practices fact sheets for drug court practitioners.

Performance Measures Development: $2 million

In FY 2004, ONDCP is requesting $2 million for Performance Measures Development. ONDCP requested $2 million in FY 2003. The FY 2003 enacted level is $1.987 million. ONDCP will use the requested funding to develop and implement data sources to monitor illegal drug use and supply for national policy-makers. Many indicators are currently lacking or inadequate for informing policy decisions. ONDCP identified program performance indicators in its annual Strategic Plan. The National Drug Control Strategy stated the necessity for monitoring key indicators tied to the Strategy's three priorities: Stopping Use Before it Starts, Healing America's Drug Users, and Disrupting the Market.

The requirement for performance indicators and key demand/supply assessments highlight the need for improving data sources, such as: a) the price and purity of illegal drugs; b) the supply of drugs flowing to the United States and the amount of drugs consumed in the United States; and c) evaluations of the effectiveness of prevention, treatment, and law enforcement programs; and d) empirical study of drug markets; and other topics. ONDCP will lead an interagency effort to address these research and data issues. As a result of this effort, ONDCP will make use of data generated to improve and refine program indicators and consider new analytical initiatives.